Köhler U, Langanke D, Sorger D, Martin R, Bilek K
Klinik für Gynäkologie und Geburtshilfe, Universität Leipzig.
Zentralbl Gynakol. 1995;117(3):148-52.
The concentration of the lysosomal protease Cathepsin D was tested by means of RIA. We used the cytosols of 44 endometrial carcinoma tissue specimens and of the corresponding normal endometrial tissues (n = 42) obtained from the respective uteri after hysterectomy. All patients were in postmenopausal stage. A significant higher level of Cathepsin D expression was found in endometrial carcinoma (median value = 24.2 pmol/mg) compared to normal endometrium (median value = 11.4 pmol/mg). No difference in Cathepsin D concentration was found in relation to grade of histological differentiation (G1 vs. G2/G3), depth of myometrial invasion and tumor stage (stage IA vs. IB/IC vs. > I) as well as state of estrogen receptor (ER) and progesterone receptor (PR). After an average follow-up period of 18 months there was no significant difference in survival rate of operated patients depending on Cathepsin D concentration. However, the prognostic significance of this parameter need to be evaluated after a long-term follow-up. The overexpression of Cathepsin D seems to be important for exact biologic characterization of each endometrial carcinoma with respect to local proteolytic activity. The enhanced activity of cathepsin D may therefore serve as an additional objective malignancy criterion independent of the well-known prognostic factors.
采用放射免疫分析法检测溶酶体蛋白酶组织蛋白酶D的浓度。我们使用了44例子宫内膜癌组织标本以及相应的正常子宫内膜组织(n = 42)的细胞溶质,这些组织均取自子宫切除术后的子宫。所有患者均处于绝经后阶段。与正常子宫内膜(中位数 = 11.4 pmol/mg)相比,子宫内膜癌中组织蛋白酶D的表达水平显著更高(中位数 = 24.2 pmol/mg)。在组织学分化程度(G1与G2/G3)、肌层浸润深度、肿瘤分期(IA期与IB/IC期与>I期)以及雌激素受体(ER)和孕激素受体(PR)状态方面,未发现组织蛋白酶D浓度存在差异。在平均随访18个月后,根据组织蛋白酶D浓度,手术患者的生存率无显著差异。然而,该参数的预后意义需要经过长期随访来评估。组织蛋白酶D的过表达似乎对于准确生物学特性的子宫内膜癌局部蛋白水解活性而言很重要。因此,组织蛋白酶D活性的增强可能作为一个独立于众所周知的预后因素的额外客观恶性标准。